Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report

Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report

<p dir="ltr">Targeting the programmed cell death protein-1 (PD-1)/PD-1 ligand (PD-L1) pathway has been shown to enhance T cell-mediated antitumor immunity. Clinical responses are limited to subgroups of patients. The search for biomarkers of response is a strategy to predict response...

Full description

Saved in:
Bibliographic Details
Main Author: Maysaloun Merhi (4246147) (author)
Other Authors: Afsheen Raza (492657) (author), Varghese Philipose Inchakalody (14153292) (author), Abdulqadir Jeprel Japer Nashwan (18090526) (author), Niloofar Allahverdi (14557403) (author), Roopesh Krishnankutty (1297770) (author), Shahab Uddin (154400) (author), Abdul Rehman Zar Gul (14777347) (author), Mohammed Ussama Al Homsi (15263542) (author), Said Dermime (79420) (author)
Published: 2018
Subjects:
Biomedical and clinical sciences
Immunology
head and neck squamous cell carcinoma
programmed cell death protein-1
nivolumab
NY-ESO-1 antibody
NY-ESO-1-specific T cells
cytokine profile
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items